Are you Dr. Singla?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 W California Blvd
Unit 25
Pasadena, CA 91105Phone+1 626-397-2390Fax+1 626-628-0384
Summary
- Dr. Neil Singla, MD is an anesthesiologist in Pasadena, California. He is currently licensed to practice medicine in California. He is affiliated with Huntington Health.
Education & Training
Loma Linda University Health Education ConsortiumResidency, Anesthesiology, 1998 - 2001
Hamot Medical CenterInternship, Transitional Year, 1996 - 1997
Northeast Ohio Medical UniversityClass of 1996
Certifications & Licensure
CA State Medical License 1997 - 2023
Clinical Trials
- Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers Start of enrollment: 2009 Nov 01
- An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS Start of enrollment: 2014 Mar 01
- An Open Label, Prospective Study of the Analgesic Efficacy of Oral Xartemis Compared to Generic Oxycodone/APAP( Acetaminophen) in the Treatment of Moderate to Severe Post Operative Pain. Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 99 citationsAPOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein–Biased Ligand at the μ-Opioid Receptor, for Manag...Neil Singla, Franck Skobieranda, David G. Soergel, Monica Y Salamea, David A. Burt
Pain Practice. 2019-06-24 - 93 citationsAPOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for manage...Eugene R. Viscusi, Franck Skobieranda, David G. Soergel, Emily Cook, David A. Burt
Journal of Pain Research. 2019-03-11 - 151 citationsPharmacokinetic Profile of Liposome Bupivacaine Injection Following a Single Administration at the Surgical SiteDeeDee Hu, Erol Onel, Neil Singla, William G. Kramer, Admir Hadzic
Clinical Drug Investigation. 2013-02-01
Press Mentions
Unintended Consequences of COVID-19 Safety Measures on Patients with Chronic Knee Pain Forced to Defer Joint Replacement SurgeryOctober 12th, 2020
Trevena Announces Publication of APOLLO-2 Results in Pain PracticeJune 24th, 2019
Accelerating Development of Non-Opioid Pain MedicinesMay 22nd, 2019- Join now to see all
